Q: Could you update your opinion of Velan given that activist investors are at work trying to improve the company, from what I hear? I would probably be looking at a 1-2 year hold in my TFSA.
Q: I have $4,200 "invested" in WILD , in my TFSA account. Currently I am down $3,600 with only $600 residual value. Thinking of accepting the full loss, selling and putting the $600 to some other use but wonder if I'm better off just holding on at this point. With no tax loss benefit, which way would you go here?
Thanks for your thoughts,
Mark
Q: I have a "friend" promoting this stock. I am always leery of these "tips" but admit I do look into them to see if there is any potential merit in a speculative play. I cannot find any meaningful info on this company. Can you share with me what you know about it.
Thanks John
Q: After a recent run to $2.75 H on Jan 16,STC retreated to $2.38 on Jan 21.Any reason? Is this a good point to add to my 1% position(p/p $2.47)especially in light of the sharp drop in Asian markets & U.S. futures today? Also your expectations of eps & revenue of its Q2 on Feb 27. Txs for u usual great services & views Looking forward to seeing Ryan on BNN,Feb 26
Q: The favour of the day is clearly companies with a large ESG factor, however the valuations are through the roof. Can you suggest some names that are still in the reasonable p/e range.
Thanks in advance.
Q: While you have not been particularly enthusiastic to this point, I would appreciate your analysis of their latest results. Clearly the market was very impressed as it cracked both the highest gainers and most heavily traded lists yesterday.
BEVERLY, Mass. and TORONTO, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading global provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year ended December 31, 2019.
Based on preliminary unaudited results, 2019 revenues increased 21% to a record $35.3 million with adjusted EBITDA for the year of approximately $7.1 million (14.6% year over year growth). Fourth quarter sales increased 34% to $10.8 million, with adjusted EBITDA estimated to increase 27% to approximately $2.2 million. Organic growth on a constant currency basis was approximately 15% for the year and approximately 20% in the fourth quarter, largely driven by sales increases of equipment and consumables. Gross profit margins were approximately 53.8% for the year and 56.4% for the fourth quarter.
Q: Hello,looking to buy, could you comment for growth and income.(Do like its portfolio of companies). It looks like a $ 4.25 target price? Or would you consider it too risky?
Would you recommend an alternative in the 5%
distribution range. Looking for growth with some safety.
Q: Based on a question from a month ago I took a half position in XBC. It’s up 43% since then (thanks!). I’m considering a full position and am okay with risk. My concern is whether there has been too large a run up in the past month, or would you still consider this early days for this stock in an emerging sector?
Q: Hi 5i Team. Thanks for your great service.
With all the renewed hype with regards to green/ESG companies, is there a need to own all of the above companies or do their services overlap? Which ones would you own?